CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
复制标题
CYP2J2 及其代谢物(环氧二十碳三烯酸)通过激活 AMPK2 和增强 Akt1 的核转位来减轻心脏肥大
DOI:
10.1111/acel.12507
复制
发表时间:
2016-10
期刊:
影响因子:
7.8
通讯作者:
Wang DW
中科院分区:
文献类型:
--
作者:
Wang B;Zeng H;Wen Z;Chen C;Wang DW
Cytochrome P450 epoyxgenase 2J2 and epoxyeicosatrienoic acids (EETs) are known to protect against cardiac hypertrophy and heart failure, which involve the activation of 5′‐AMP‐activated protein kinase (AMPK) and Akt. Although the functional roles of AMPK and Akt are well established, the significance of cross talk between them in the development of cardiac hypertrophy and antihypertrophy of CYP2J2 and EETs remains unclear. We investigated whether CYP2J2 and its metabolites EETs protected against cardiac hypertrophy by activating AMPKα2 and Akt1. Moreover, we tested whether EETs enhanced cross talk between AMPKα2 and phosphorylated Akt1 (p‐Akt1), and stimulated nuclear translocation of p‐Akt1, to exert their antihypertrophic effects. AMPKα2−/− mice that overexpressed CYP2J2 in heart were treated with Ang II for 2 weeks. Interestingly, overexpression of CYP2J2 suppressed cardiac hypertrophy and increased levels of atrial natriuretic peptide (ANP) in the heart tissue and plasma of wild‐type mice but not AMPKα2−/− mice. The CYP2J2 metabolites, 11,12‐EET, activated AMPKα2 to induce nuclear translocation of p‐Akt1 selectively, which increased the production of ANP and therefore inhibited the development of cardiac hypertrophy. Furthermore, by co‐immunoprecipitation analysis, we found that AMPKα2β2γ1 and p‐Akt1 interact through the direct binding of the AMPKγ1 subunit to the Akt1 protein kinase domain. This interaction was enhanced by 11,12‐EET. Our studies reveal a novel mechanism in which CYP2J2 and EETs enhanced Akt1 nuclear translocation through interaction with AMPKα2β2γ1 and protect against cardiac hypertrophy and suggest that overexpression of CYP2J2 might have clinical potential to suppress cardiac hypertrophy and heart failure.
登录
查看更多内容
DOI:
10.1046/j.1432-1327.1999.00774.x
发表时间:
1999-10-01
期刊:
EUROPEAN JOURNAL OF BIOCHEMISTRY
影响因子:
--
作者:
Masure, S;Haefner, B;Richardson, A
通讯作者:
Richardson, A
影响因子:
120.7
作者:
Redfield, MM;Jacobsen, SJ;Rodeheffer, RJ
通讯作者:
Rodeheffer, RJ
影响因子:
10.8
作者:
Guo, Rui;Ren, Jun
通讯作者:
Ren, Jun
DOI:
10.1073/pnas.1103300108
发表时间:
2011-11-08
影响因子:
11.1
作者:
Klaiber, Michael;Dankworth, Beatrice;Kuhn, Michaela
通讯作者:
Kuhn, Michaela
影响因子:
4.8
作者:
Andjelkovic, M;Alessi, DR;Hemmings, BA
通讯作者:
Hemmings, BA